Oxford BioMedica completes purchase of last 10% stake in US subsidiary
(Alliance News) - Oxford BioMedica PLC on Monday said it has completed the acquisition of the remaining 10% stake in its US subsidiary from Massachusetts, US-based biotechnology firm Q32 Bio Inc. Read More